Pembrolizumab vs Sars-Cov-2 Virus Spike Protein

## Pembrolizumab vs Sars-Cov-2 Virus Spike Protein: Overview

This comparison examines the pharmacological differences between **Pembrolizumab** and **Sars-Cov-2 Virus Spike Protein**.

## Mechanism of Action

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Pembrolizumab — 26 days; Sars-Cov-2 Virus Spike Protein — N/A.

## Chemical Properties

**Type**: Pembrolizumab — Antibody; Sars-Cov-2 Virus Spike Protein — Vaccine component.